Annovis Bio's market cap is currently $43.45M. The company's EPS TTM is $-0.32; its P/E ratio is ―; Annovis Bio is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
